Pierre Fabre Medicament

Frédéric Lieby-Muller

Frédéric Marion

Michel Perez

El Bachir Kaloun

Jean-Philippe Annereau

Serge Grisoni

Laurent Creancier

Nicolas Rahier

Isabelle Sartori

Emmannuel Fournier

The invention relates to compounds of the following general formula (I) in the form of one of the enantiomers thereof or a mixture of the enantiomers thereof, and the pharmaceutically acceptable salts and/or solvates thereof, especially for the use thereof as a medicament, more specifically in cancer treatment. The invention also relates to pharmaceutical compositions containing same and to the methods for the production thereof.

Flavagline derivatives

The present invention relates to compounds of the following general formula (I), or to a pharmaceutically acceptable salt thereof, as well as to the uses thereof as a drug, in particular for treating cancerous or precancerous hyperproliferative conditions, and to the pharmaceutical compositions containing same. 

Griseofulvin derivatives

The present invention relates to compounds of the following general formula (I), or to a pharmaceutically acceptable salt thereof, as well as to the uses thereof as a drug, in particular in the treatment of cancerous or precancerous hyperproliferative conditions, and to the pharmaceutical compositions containing same. 

Growing community of inventors

Portet-sur-Garonne, France

Frédéric Lieby-Muller